FORT LAUDERDALE, Fla., Dec. 10 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC:SYVC) (BULLETIN BOARD: SYVC) , a specialty pharmaceutical company, today announced a further...
FORT LAUDERDALE, Fla., July 10 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC:SYVC) (BULLETIN BOARD: SYVC) , a specialty pharmaceutical company, today announced that Mr. Jyotindra...
FORT LAUDERDALE, Fla., June 24 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC:SYVC) (BULLETIN BOARD: SYVC) , a specialty pharmaceutical company, today announced that its wholly...
FORT LAUDERDALE, Fla., June 18 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC:SYVC) (BULLETIN BOARD: SYVC) , a specialty pharmaceutical company, today announced that its wholly...
FORT LAUDERDALE, Fla., June 17 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC:SYVC) (BULLETIN BOARD: SYVC) , a specialty pharmaceutical company, filed its second quarter, 2008...
FT. LAUDERDALE, Fla., June 12 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc., (OTC:SYVC) (BULLETIN BOARD: SYVC) a specialty pharmaceutical company, announced today that on June 6...
Synovics Pharmaceuticals, Inc. (OTCBB:SYVC), a specialty pharmaceutical company, today announced that on July 31, 2007, the Company together with its subsidiary Synovics...
Synovics Pharmaceuticals, Inc., (OTCBB:SYVC) a specialty pharmaceutical company, today announced that Steven Getraer has been appointed Executive Vice President and Chief...
Synovics Pharmaceuticals, Inc. (OTCBB:SYVC), a specialty pharmaceutical company, today announced that its wholly owned subsidiary, Kirk Pharmaceuticals, LLC (Kirk), has become a...
Synovics Pharmaceuticals, Inc. (OTCBB:SYVC), a specialty pharmaceutical company, today announced it has finalized a definitive agreement for a previously announced binding...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
52 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
156 | -0.0001 | -50 | 0.0002 | 0.0002 | 1.0E-6 | 1275 | 8.432E-5 | CS |
260 | 0 | 0 | 0.0001 | 0.0002 | 1.0E-6 | 1189 | 8.604E-5 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales